We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

004990:KRXLotte Corp Analysis

Data as of 2026-03-17 - not real-time

₩30,500.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

LOTTE Corp. trades at 30,500 KRW, comfortably above its 200‑day SMA (29,509 KRW) but below the 20‑day (33,305 KRW) and 50‑day (30,720 KRW) averages, suggesting a bullish long‑term bias yet short‑term weakness. The RSI sits at 44.5, indicating neutral momentum, while the MACD histogram is firmly negative and the signal line is labeled “bearish,” pointing to deteriorating price momentum. Volume has been decreasing, adding pressure to the near‑term outlook. On the valuation side, the DCF‑derived fair value of ~57,952 KRW implies roughly 30% upside, classifying the stock as undervalued relative to intrinsic estimates. However, the fundamentals are strained: a negative profit margin (‑6.5%), a hefty debt‑to‑equity ratio (~110), and negative free cash flow (~‑550 bn KRW) raise concerns about earnings sustainability. The dividend yield remains attractive at 4.16%, but with zero EPS and a payout ratio of 0, the dividend’s durability is questionable. Market sentiment is highly optimistic, reflected by an “Extreme Greed” fear‑greed index (77.9) and a low beta (~0.28), yet the 30‑day volatility of 67.5% and a max drawdown of ‑28% underscore significant price swings. Overall, the stock presents a classic value play with notable financial risk, making it a candidate for investors who can tolerate volatility and monitor the company’s debt reduction and cash‑flow turnaround.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and decreasing volume
  • Neutral RSI signaling limited upside
  • Attractive dividend yield but sustainability concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF upside of ~30% indicating undervaluation
  • Price above 200‑day SMA supporting bullish trend
  • Potential for debt reduction and cash‑flow improvement

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity and negative free cash flow
  • Stable consumer‑defensive sector offering resilience
  • Long‑term dividend yield attractive if earnings recover

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin-6.47%
P/E Ratio-32.2
ROE-9.90%
ROA0.73%
Debt/Equity110.16
Op. Cash Flow₩1201.6B
Free Cash Flow₩-549907529728

Technical Analysis

TrendBullish
RSI44.5
Support₩28,600.00
Resistance₩39,600.00
MA 20₩33,305.00
MA 50₩30,720.00
MA 200₩29,509.25
MACDBearish
VolumeDecreasing
Fear & Greed Index77.91

Valuation

Fair Value₩57,951.70
Target Price₩39,500.00
Upside/Downside29.51%
GradeUndervalued
TypeValue
Dividend Yield4.16%

Risk Assessment

Beta0.28
Volatility67.55%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.